List of works by Charlotte Charpentier

A new mechanism of resistance of HIV-2 to integrase inhibitors: a 5 amino-acids insertion in the integrase C-terminal domain

article

Antiretroviral-Experienced HIV-1-Infected Patients Treated with Maraviroc: Factors Associated with Virological Response

scientific article published on 17 December 2014

Association of soluble CD14 and inflammatory biomarkers with HIV-2 disease progression

scientific article

Baseline genotypic and phenotypic susceptibilities of HIV-1 group O to enfuvirtide

scientific article

Budget impact of antiretroviral therapy in a French clinic cohort

scientific article published on 18 March 2017

Cellular HIV-1 DNA quantification and short-term and long-term response to antiretroviral therapy.

scientific article published on 27 April 2011

Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical Isolates

scientific article published on 6 August 2015

Change in HIV-1 DNA tropism despite virological success in patients receiving an enfuvirtide-based regimen.

scientific article published on 9 May 2014

Characterization of CRF56_cpx, a new circulating B/CRF02/G recombinant form identified in MSM in France

scientific article published on September 2013

Combinatorial prevention of HIV transmission in women: the case for a vaginal microbicide

scientific article published on July 2011

Concordance between HIV-2 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNA

article

Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients

scientific article published on 3 January 2015

Description of the L76V resistance protease mutation in HIV-1 B and "non-B" subtypes

scientific article

Differential activity of candidate microbicides against early steps of HIV-1 infection upon complement virus opsonization

scientific article

Distribution of HIV-1 and HSV-2 epidemics in Chad revealing HSV-2 hot-spot in regions of high-risk HIV spread.

scientific article published on January 2011

Dolutegravir in HIV-2-Infected Patients With Resistant Virus to First-line Integrase Inhibitors From the French Named Patient Program

scientific article published on 17 February 2015

Dynamics of enfuvirtide resistance mutations in enfuvirtide-experienced patients remaining in virological failure under salvage therapy.

scientific article published on 22 February 2011

Dynamics of gag-pol minority viral populations in naive HIV-1-infected patients failing protease inhibitor regimen.

scientific article published in November 2011

Early archives of genetically-restricted proviral DNA in the female genital tract after heterosexual transmission of HIV-1.

scientific article

Efficiency of HIV-2 cultures from clinical isolates is enhanced after purification by anti-CD44 microbeads.

scientific article published on 24 March 2018

Epidemiological Profile of Newly Diagnosed HIV-Infected Patients in Northern Paris: A Retrospective Study

scientific article published on 31 July 2016

Evaluation of different analysis pipelines for the detection of HIV-1 minority resistant variants.

scientific article published in June 2018

Evaluation of four tenofovir-containing regimens as first-line treatments in Cameroon and Senegal: the ANRS 12115 DAYANA Trial

scientific article published on 23 August 2013

Evaluation of the genotypic prediction of HIV-1 coreceptor use versus a phenotypic assay and correlation with the virological response to maraviroc: the ANRS GenoTropism study

scientific article

Evolution of the K65R, K103N and M184V/I reverse transcriptase mutations in HIV-1-infected patients experiencing virological failure between 2005 and 2010.

scientific article published on 7 June 2013

Extended use of raltegravir in the treatment of HIV-1 infection: optimizing therapy

scientific article

Extensive recombination among human immunodeficiency virus type 1 quasispecies makes an important contribution to viral diversity in individual patients

scientific article

Factors associated with virological response to etravirine in nonnucleoside reverse transcriptase inhibitor-experienced HIV-1-infected patients

scientific article

First line raltegravir/emtricitabine/tenofovir combination in HIV-2 infection: phase 2 non-comparative trial (ANRS 159 HIV-2).

scientific article published on 24 March 2018

Foscarnet as salvage therapy in HIV-2-infected patient with antiretroviral treatment failure.

scientific article published on 3 December 2009

Foscarnet salvage therapy efficacy is associated with the presence of thymidine-associated mutations (TAMs) in HIV-infected patients

scientific article published on 28 August 2008

Foscarnet, zidovudine and dolutegravir combination efficacy and tolerability for late stage HIV salvage therapy: A case-series experience

scientific article

Functional diversity of HIV-1 envelope proteins expressed by contemporaneous plasma viruses

scientific article published on 29 February 2008

G140S/Q148R and N155H mutations render HIV-2 Integrase resistant to raltegravir whereas Y143C does not.

scientific article

Genetic barrier for attachment inhibitor BMS-626529 resistance in HIV-1 B and non-B subtypes

scientific article published on 30 September 2014

Genotypic resistance profiles of HIV-2-treated patients in West Africa

scientific article

HIV-1 Coreceptor Usage Assessment by Ultra-Deep Pyrosequencing and Response to Maraviroc

scientific article published on 11 June 2015

HIV-1 DNA ultra-deep sequencing analysis at initiation of the dual therapy dolutegravir + lamivudine in the maintenance DOLULAM pilot study

scientific article

HIV-1 group O infection in France: clinical features and immunovirological response to antiretrovirals

scientific article published on 21 December 2017

HIV-2 Primary Infection in a French 69-Year-Old Bisexual Man

article

HIV-2 Vif Diversity Among Defective and Nondefective Sequences

scientific article

HIV-2 X4 tropism is associated with lower CD4+ cell count in treatment-experienced patients

scientific article published on September 2014

HIV-2EU-Supporting Standardized HIV-2 Drug-Resistance Interpretation in Europe: An Update

scientific article published on 17 July 2015

HIV-2EU: supporting standardized HIV-2 drug resistance interpretation in Europe

scientific article published on 19 February 2013

HPV 16 in squamous cell carcinoma of 19th century tonsils

scientific article published in November 2016

High frequency of antiretroviral drug resistance among HIV-infected adults receiving first-line highly active antiretroviral therapy in N'Djamena, Chad

scientific article published in July 2009

High frequency of integrase Q148R minority variants in HIV-infected patients naive of integrase inhibitors.

scientific article published in March 2010

High level of APOBEC3F/3G editing in HIV-2 DNA vif and pol sequences from antiretroviral-naive patients

scientific article published on April 2015

High predictive efficacy of integrase strand transfer inhibitors in perinatally HIV-1-infected African children in therapeutic failure of first- and second-line antiretroviral drug regimens recommended by the WHO.

scientific article

High prevalence of antiretroviral drug resistance among HIV-1-untreated patients in Guinea-Conakry and in Niger

scientific article published in January 2011

High prevalence of antiretroviral drug resistance mutations in HIV-1 non-B subtype strains from African children receiving antiretroviral therapy regimen according to the 2006 revised WHO recommendations

scientific article published in December 2008

High rate of antiretroviral drug resistance mutations in HIV type 1-infected Senegalese children in virological failure on first-line treatment according to the World Health Organization guidelines

scientific article published on 3 August 2012

High virological suppression regardless of the genotypic susceptibility score after switching to a dolutegravir-based regimen: week 48 results in an observational cohort.

scientific article

Highly frequent HIV-1 minority resistant variants at baseline of the ANRS 139 TRIO trial had a limited impact on virological response

scientific article published on 8 March 2015

Hiv-2 molecular epidemiology

scientific article published on 12 August 2016

Hot spots of integrase genotypic changes leading to HIV-2 resistance to raltegravir

scientific article

Identification of a rare mutation at reverse transcriptase Lys65 (K65E) in HIV-1-infected patients failing on nucleos(t)ide reverse transcriptase inhibitors

scientific article published on 7 June 2013

Illegal gold miners in French Guiana: a neglected population with poor health

scientific article

Impact of Adding Enfuvirtide to the Predictive Value of the Darunavir Genotypic Resistance Score

scientific article published on 01 May 2011

Impact of HIV-1 group O genetic diversity on genotypic resistance interpretation by algorithms designed for HIV-1 group M.

scientific article published in February 2011

Impact of HIV-1 minority variants on the virus response to a rilpivirine-based first line regimen

scientific article published on 13 December 2017

Impact of gag genetic determinants on virological outcome to boosted lopinavir-containing regimen in HIV-2-infected patients

scientific article

Impact of lopinavir/ritonavir use on antiretroviral resistance in recent clinical practice

scientific article published on 25 June 2012

Impact of natural polymorphisms of HIV-1 non-group M on genotypic susceptibility to the attachment inhibitor fostemsavir

article

Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case-control study

scientific article published on 8 January 2017

In vitro phenotypic susceptibility of HIV-2 clinical isolates to CCR5 inhibitors

scientific article published on 7 November 2011

In vitro synergistic activity against CCR5-tropic HIV-1 with combinations of potential candidate microbicide molecules HHA, KRV2110 and enfuvirtide (T20).

scientific article published on 29 October 2009

In-vitro phenotypic susceptibility of HIV-1 'non-B' integrase inhibitors naive clinical isolates to dolutegravir and raltegravir

scientific article published on November 2013

In-vitro phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitor S/GSK1349572.

scientific article published on November 2010

Increased Polymorphism in the HR-1 gp41 env Gene Encoding the Enfuvirtide (T-20) Target in HIV-1 Variants Harboring Multiple Antiretroviral Drug Resistance Mutations in the pol Gene

article

Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France

scientific article published on 21 October 2010

Intensification of antiretroviral therapy through addition of enfuvirtide in naive HIV-1-infected patients with severe immunosuppression does not improve immunological response: results of a randomized multicenter trial (ANRS 130 Apollo)

scientific article published on 19 November 2012

Interest of cytology combined with Xpert® HPV and Anyplex® II HPV28 Detection human papillomavirus (HPV) typing: differential profiles of anal and cervical HPV lesions in HIV-infected patients on antiretroviral therapy

scientific article published on 30 July 2018

Less frequent follow-up in routine care than in trials does not impact resistance selection in patients failing DRV/r or ATV/r first line treatment

scientific article published on 2 November 2014

Levels of intracellular HIV-DNA in patients with suppressive antiretroviral therapy

scientific article published on August 2015

Long-lasting persistence of integrase resistance mutations in HIV-2-infected patients after raltegravir withdrawal.

scientific article published in January 2011

Long-term efficacy and safety of raltegravir, etravirine, and darunavir/ritonavir in treatment-experienced patients: week 96 results from the ANRS 139 TRIO trial

scientific article published on 01 April 2012

Longitudinal analysis of raltegravir susceptibility and integrase replication capacity of human immunodeficiency virus type 1 during virologic failure

scientific article

Low genetic barrier to large increases in HIV-1 cross-resistance to protease inhibitors during salvage therapy

scientific article published on 01 January 2006

Minority resistant variants are also present in HIV-2-infected antiretroviral-naive patients

scientific article published on 3 February 2018

Molecular determinants of HIV-2 R5-X4 tropism in the V3 loop: development of a new genotypic tool

scientific article

Multicenter comparison of the new Cobas 6800 system with Cobas Ampliprep/Cobas TaqMan and Abbott RealTime for the quantification of HIV, HBV and HCV viral load

scientific article published on 20 September 2017

Multicenter quality control of hepatitis C virus protease inhibitor resistance genotyping

scientific article published on 20 February 2013

Mutation V111I in HIV-2 reverse transcriptase increases the fitness of the nucleoside analogue-resistant K65R and Q151M viruses

scientific article

Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration

scientific article published on 19 March 2017

Mutations Located outside the Integrase Gene Can Confer Resistance to HIV-1 Integrase Strand Transfer Inhibitors

scientific article published on 26 September 2017

National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011.

scientific article

Natural evolution of CD4+ cell count in patients with CD4 >350 or >500  cells/mm3 at the time of diagnosis according to HIV-1 coreceptor tropism

scientific article

No impact of HIV-1 protease minority resistant variants on the virological response to a first-line PI-based regimen containing darunavir or atazanavir

scientific article

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine

scientific article published on June 2013

Occurrence of Extensive Cutaneous Human Papillomavirus Infection After Initiation of Tofacitinib Therapy.

scientific article published on 13 March 2019

Persistent low-level HIV-1 RNA between 20 and 50 copies/mL in antiretroviral-treated patients: associated factors and virological outcome

scientific article published on 29 May 2012

Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen

scientific article published on 12 January 2018

Pitfalls of antiretroviral drug resistance genotyping of HIV-1 Group M and Group N from Cameroon by sequenced-based assays

scientific article published on November 2015

Positive Virological Outcomes of HIV-Infected Patients on Protease Inhibitor-Based Second-Line Regimen in Cambodia: The ANRS 12276 2PICAM Study.

scientific article published on 19 March 2018

Positive impact of HIV-1 gag cleavage site mutations on the virological response to darunavir boosted with ritonavir

scientific article published on 31 January 2011

Pre-clinical development as microbicide of zinc tetra-ascorbo-camphorate, a novel terpenoid derivative: potent in vitro inhibitory activity against both R5- and X4-tropic HIV-1 strains without significant in vivo mucosal toxicity.

scientific article published on 3 June 2008

Predictive value of liver enzymes and inflammatory biomarkers for the severity of liver fibrosis stage in HIV/HCV co-infected patients

scientific article

Prevalence of HIV-1 drug resistance among patients failing first-line ART in Monrovia, Liberia: a cross-sectional study

scientific article published on 18 February 2015

Prevalence of gag mutations associated with in vitro resistance to capsid inhibitor GS-CA1 in HIV-1 antiretroviral-naive patients.

scientific article

Prevalence of respiratory viruses among adults, by season, age, respiratory tract region and type of medical unit in Paris, France, from 2011 to 2016

scientific article

Prevalence of subtype-related polymorphisms associated with in vitro resistance to attachment inhibitor BMS-626529 in HIV-1 'non-B'-infected patients

scientific article published on 01 March 2012

Reply to Das and Berkhout, "How Polypurine Tract Changes in the HIV-1 RNA Genome Can Cause Resistance against the Integrase Inhibitor Dolutegravir".

scientific article published on 29 May 2018

Residual HIV-1 RNA and HIV-1 DNA production in the genital tract reservoir of women treated with HAART: the prospective ANRS EP24 GYNODYN study

scientific article published in January 2011

Resistance analyses in highly experienced patients failing raltegravir, etravirine and darunavir/ritonavir regimen ⬇️

scientific article published on November 13, 2010

Resistance profiles of emtricitabine and lamivudine in tenofovir-containing regimens

scientific article published on 26 February 2012

Resistance to HIV Integrase Inhibitors: About R263K and E157Q Mutations

scientific article published on 18 January 2018

Role and evolution of viral tropism in patients with advanced HIV disease receiving intensified initial regimen in the ANRS 130 APOLLO trial

scientific article

Role of baseline HIV-1 DNA level in highly-experienced patients receiving raltegravir, etravirine and darunavir/ritonavir regimen (ANRS139 TRIO trial).

scientific article

Role of minority populations of human immunodeficiency virus type 1 in the evolution of viral resistance to protease inhibitors.

scientific article published on April 2004

Short communication: Prevalence of HIV-1 transmitted drug resistance in Liberia

scientific article published on 14 July 2014

Surveillance of antiretroviral drug resistance mutations in untreated young children living in the Central African Republic

scientific article published in January 2011

Sustained virological failure in Cameroonese patient infected by HIV-1 group N evidenced by sequence-based genotyping assay

scientific article published in June 2015

Switch as maintenance to elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate: week 48 results in a clinical cohort

scientific article published on 10 February 2017

Tenofovir plasma concentrations related to estimated glomerular filtration rate changes in first-line regimens in African HIV-infected patients: ANRS 12115 DAYANA substudy

scientific article published on 11 January 2015

The HIV-1 integrase G118R mutation confers raltegravir resistance to the CRF02_AG HIV-1 subtype.

scientific article published on 19 September 2011

Tipranavir-ritonavir genotypic resistance score in protease inhibitor-experienced patients

scientific article published on 14 July 2008

Transmitted drug resistance in French HIV-2-infected patients

scientific article

Tropism distribution among antiretroviral-naive HIV-2-infected patients

scientific article published on October 2015

Use of PCR Signal and Therapeutic Drug Monitoring in a Switch Cohort Study to Tenofovir/Emtricitabine/Rilpivirine: A W96 Follow-Up

scientific article

Usefulness of a genotypic resistance test using dried blood spot specimens in African HIV-infected children with virological failure according to the 2010-revised WHO criteria

scientific article

Usefulness of multiplex PCR methods and respiratory viruses' distribution in children below 15 years old according to age, seasons and clinical units in France: A 3 years retrospective study

scientific article

Virological failure and HIV type 1 drug resistance profiles among patients followed-up in private sector, Douala, Cameroon

scientific article published on 26 October 2010

Virological outcome at week 48 of three recommended first-line regimens using ultrasensitive viral load and plasma drug assay

scientific article published on 19 June 2014

Virological response and resistance profiles after 18 to 30 months of first- or second-/third-line antiretroviral treatment: a cross-sectional evaluation in HIV type 1-infected children living in the Central African Republic

scientific article published on 20 June 2011

Virological response and resistance profiles after 24 months of first-line antiretroviral treatment in adults living in Bangui, Central African Republic

scientific article published on 23 September 2011

Zika virus in the female genital tract

scientific article published in November 2016

Paulina is supported by:

About Paulina

Help